Trials / Conditions / Relapsed/Refractory Acute Myeloid Leukaemia
Relapsed/Refractory Acute Myeloid Leukaemia
3 registered clinical trials studyying Relapsed/Refractory Acute Myeloid Leukaemia — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML NCT06621212 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Recruiting | Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AML NCT06434662 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Recruiting | Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML NCT04501120 | Ascentage Pharma Group Inc. | Phase 1 / Phase 2 |